Introduction Recent advances in the field of immunotherapy have revolutionized the treatment of cancer and have given hope to patients with cancers that were associated with a poor prognosis. Immune therapies have now been US Food and Drug Administration (FDA)–approved…
Introduction Cancer immunotherapy has a rich history. In the late 19th century, William Coley treated sarcoma patients with intratumoral bacteria and bacterial products and demonstrated tumor shrinkage. Over the years, we have added significantly to the “immunological armament” against cancer.…
Introduction Novel agents have revolutionized the treatment of cancer, resulting in many benefits for patients. These same agents, however, have been associated with new toxicity profiles compared with traditional chemotherapy. Most of these adverse events have been classified as mild…
Introduction In the past two decades, the field of cancer immunotherapy evolved from a niche specialty to the frontlines of the fight against cancer. Unlike chemotherapy, immunotherapy unleashes the body’s inherent immune system by boosting it and “releasing its breaks.”…